News from omeros corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Bloomberg:RTRKS,RICS:RTRKS)

Aug 18, 2015, 07:00 ET

Omeros Announces Additional Positive Data in OMS721 Phase 2 Clinical Trial

Omeros Corporation (NASDAQ: OMER) today announced additional positive data in the company's Phase 2 clinical trial of OMS721 for the treatment of...

Aug 17, 2015, 07:00 ET

Omeros Announces Plan to File Infringement Suit Against ANDA Filer

 Omeros Corporation (NASDAQ: OMER) today, in response to investor questions, announced that it plans to file a patent infringement lawsuit...

Aug 10, 2015, 16:11 ET

Omeros Corporation Reports Second Quarter 2015 Financial Results

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule...

Aug 07, 2015, 07:00 ET

Omeros to Present at the 2015 Wedbush PacGrow Healthcare Conference

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...

Aug 03, 2015, 07:00 ET

Omidria® Approved for Commercialization Throughout the European Union and Additional Countries

 Omeros Corporation (NASDAQ: OMER) today announced that the European Commission (EC) has granted marketing authorization for Omidria...

Jul 31, 2015, 16:50 ET

Omeros Corporation to Announce Second Quarter 2015 Financial Results on August 10, 2015

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule...

Jul 23, 2015, 07:00 ET

FDA Grants "Fast Track" to Omeros' Complement Inhibitor OMS721 for aHUS

 Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation to OMS721...

Jun 17, 2015, 07:00 ET

Rajiv Shah, M.D., Appointed to Omeros' Board of Directors

 Omeros Corporation (NASDAQ: OMER) today announced that Rajiv Shah, M.D., recent Administrator of the United States Agency for International...

Jun 16, 2015, 07:00 ET

Omeros Announces Exclusive License Agreement for Omeros' Arthroscopic Product OMS103

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...

May 22, 2015, 07:00 ET

Omidria® Receives Positive Opinion from European Medicines Agency's Committee for Medicinal Products for Human Use

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...

May 11, 2015, 16:06 ET

Omeros Corporation Reports First Quarter 2015 Financial Results

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule...

May 05, 2015, 07:00 ET

Omeros Corporation to Announce First Quarter 2015 Financial Results on May 11, 2015

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and...

Apr 14, 2015, 07:00 ET

European Regulatory Authority Approves Clinical Investigator's Request for Compassionate Use with Omeros Corporation's OMS721

 Omeros Corporation (NASDAQ: OMER) today announced that the presiding European regulatory authority has approved the company's investigational...

Apr 09, 2015, 16:31 ET

Omeros to Present at the 14th Annual Needham Healthcare Conference

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...

Apr 02, 2015, 08:15 ET
Omeros logo

Omeros Corporation Announces the U.S. Commercial Launch of Omidria™

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein...

Mar 16, 2015, 16:05 ET

Omeros Corporation Reports Fourth Quarter and Year-End 2014 Financial Results

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...

Mar 09, 2015, 18:03 ET

Omeros Corporation to Announce Fourth Quarter and Full-Year 2014 Financial Results on March 16, 2015

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and...

Feb 19, 2015, 07:00 ET

Omeros Corporation's Phase 2 OMS721 Trial Resulting in Extended Access for Compassionate Use

Omeros Corporation (NASDAQ: OMER) today announced that it has completed dosing of the low-dose cohort of patients in its ongoing Phase 2 clinical...

Feb 03, 2015, 17:01 ET

Omeros Closes $84 Million Public Offering of Common Stock and Pre-Funded Warrants

Omeros Corporation (NASDAQ: OMER) today announced that it has closed the underwritten public offering that was priced and allocated to investors on...

Jan 29, 2015, 08:32 ET

Omeros Prices $75 Million Public Offering of Common Stock and Pre-Funded Warrants

Omeros Corporation (NASDAQ: OMER) today announced that it has priced an underwritten public offering of 2,995,506 shares of its common stock at a...